ZimVie’s 2021 revenue, NuVasive wins $1.6M and more: 6 device company notes

NuVasive’s court win, payer approval of artificial disc replacement and four more updates from spine devicemakers in the last week:

Advertisement

1. A judge for the U.S. District Court of the District of Massachusetts awarded NuVasive $1.6 million in damages after finding a former employee of the devicemaker breached his noncompete and nonsolicitation clauses.

2. ZimVie, Zimmer Biomet’s spine and dental spinoff company, cracked $1 billion in third-party revenue and is on track to see similar results in 2022.

3. Stefan Renaud, DO, performed the first case with Amplify Surgical’s 15-degree lordotic DualX interbody fusion implant. 

4. SpineGuard’s PediGuard threaded instrument was cleared by the FDA for anterior approach spine procedures.

5. A third-party payer established positive coverage for one- and two-level lumbar disc replacement with Centinel Spine’s Prodisc L, the devicemaker said April 5.

6. Restor3d, a musculoskeletal devicemaker, raised $23 million to expand the delivery of personalized 3D-printed implants and to develop software for engineers.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.